Millennium Management LLC Has $5.24 Million Stake in NanoString Technologies Inc (NSTG)

Share on StockTwits

Millennium Management LLC grew its stake in NanoString Technologies Inc (NASDAQ:NSTG) by 51.0% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 353,432 shares of the biotechnology company’s stock after buying an additional 119,428 shares during the quarter. Millennium Management LLC’s holdings in NanoString Technologies were worth $5,241,000 as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of NSTG. Point72 Asset Management L.P. acquired a new position in shares of NanoString Technologies in the 3rd quarter valued at about $7,132,000. BlackRock Inc. lifted its holdings in shares of NanoString Technologies by 19.4% in the 3rd quarter. BlackRock Inc. now owns 2,211,521 shares of the biotechnology company’s stock valued at $39,432,000 after buying an additional 358,991 shares during the period. Morgan Stanley raised its holdings in NanoString Technologies by 16.6% in the 3rd quarter. Morgan Stanley now owns 1,807,118 shares of the biotechnology company’s stock worth $32,221,000 after purchasing an additional 257,703 shares during the period. Neuberger Berman Group LLC raised its holdings in NanoString Technologies by 22.9% in the 3rd quarter. Neuberger Berman Group LLC now owns 1,232,787 shares of the biotechnology company’s stock worth $21,980,000 after purchasing an additional 229,486 shares during the period. Finally, Marshall Wace LLP acquired a new position in NanoString Technologies in the 3rd quarter worth about $3,430,000. 87.94% of the stock is owned by institutional investors and hedge funds.

In other NanoString Technologies news, major shareholder Lifesciences Ii L.P. Clarus sold 2,000,000 shares of the stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $21.62, for a total transaction of $43,240,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Mary Tedd Allen sold 15,000 shares of the stock in a transaction that occurred on Tuesday, January 15th. The shares were sold at an average price of $21.34, for a total value of $320,100.00. Following the transaction, the senior vice president now directly owns 28,789 shares of the company’s stock, valued at approximately $614,357.26. The disclosure for this sale can be found here. Insiders sold a total of 2,103,141 shares of company stock valued at $44,216,451 in the last ninety days. 20.90% of the stock is currently owned by insiders.

A number of equities analysts recently weighed in on the company. Zacks Investment Research raised NanoString Technologies from a “sell” rating to a “hold” rating in a report on Saturday. ValuEngine cut NanoString Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 18th. BidaskClub cut NanoString Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Finally, JPMorgan Chase & Co. reaffirmed an “overweight” rating and issued a $35.00 price target on shares of NanoString Technologies in a report on Friday, March 8th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $22.80.

NASDAQ NSTG opened at $25.98 on Monday. The stock has a market capitalization of $813.81 million, a P/E ratio of -9.35 and a beta of 1.30. NanoString Technologies Inc has a twelve month low of $8.97 and a twelve month high of $31.14. The company has a quick ratio of 2.75, a current ratio of 3.05 and a debt-to-equity ratio of 1.58.

NanoString Technologies (NASDAQ:NSTG) last released its quarterly earnings results on Thursday, March 7th. The biotechnology company reported ($0.68) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.18). The business had revenue of $30.03 million during the quarter. NanoString Technologies had a negative return on equity of 252.59% and a negative net margin of 72.52%. As a group, equities research analysts expect that NanoString Technologies Inc will post -2.36 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Millennium Management LLC Has $5.24 Million Stake in NanoString Technologies Inc (NSTG)” was posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another publication, it was copied illegally and republished in violation of US and international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/4294173/millennium-management-llc-has-5-24-million-stake-in-nanostring-technologies-inc-nstg.html.

NanoString Technologies Company Profile

NanoString Technologies, Inc provides life science tools for translational research and molecular diagnostic products worldwide. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files.

Featured Article: Asset Allocation, Balancing Your Investments

Want to see what other hedge funds are holding NSTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NanoString Technologies Inc (NASDAQ:NSTG).

Institutional Ownership by Quarter for NanoString Technologies (NASDAQ:NSTG)

Receive News & Ratings for NanoString Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NanoString Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Sabre Insurance Group  Stock Rating Reaffirmed by Numis Securities
Sabre Insurance Group Stock Rating Reaffirmed by Numis Securities
SSE  PT Lowered to GBX 1,050
SSE PT Lowered to GBX 1,050
Vectura Group  Earns Hold Rating from Peel Hunt
Vectura Group Earns Hold Rating from Peel Hunt
Critical Survey: Puhui Wealth Investment Managemnt  and Great Elm Capital
Critical Survey: Puhui Wealth Investment Managemnt and Great Elm Capital
Zacks Investment Research Downgrades Lumentum  to Sell
Zacks Investment Research Downgrades Lumentum to Sell
Innophos  Rating Lowered to C+ at TheStreet
Innophos Rating Lowered to C+ at TheStreet


© 2006-2019 Ticker Report